AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35842610 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg) combined with 30 mL of 0.33% ropivacaine
Number of subjects: 70
Study 35842610 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine (0.5 μg/kg) combined with 20 mL of 0.5% ropivacaine
Number of subjects: 70
Study 32622816 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 31
Study 32622816 — intervention group
Group type: EXPERIMENTAL
Intervention: Thought Field Therapy (TFT)
Number of subjects: 31
Study 32622816 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) followed by Thought Field Therapy (TFT)
Number of subjects: 31
Study 32144833 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol 1,000 mg per day for 8 weeks
Number of subjects: 76
Study 32144833 — intervention group
Group type: COMPARATOR
Intervention: Placebo (methylcellulose)
Number of subjects: 76
Study 33749362 — intervention group
Group type: EXPERIMENTAL
Intervention: Childcare PhysicaL ActivitY (PLAY) policy implemented by Early Childhood Educators for 8 weeks
Number of subjects: 21
Study 33749362 — intervention group
Group type: EXPERIMENTAL
Intervention: Program evaluation surveys and interviews conducted post-intervention
Number of subjects: 21
Study 33749362 — intervention group
Group type: EXPERIMENTAL
Intervention: Thematic analysis of interviews
Number of subjects: 21
Study 34554634 — intervention group
Group type: EXPERIMENTAL
Intervention: PURE EP™ system (PURE)
Number of subjects: 51
Study 34554634 — intervention group
Group type: COMPARATOR
Intervention: Conventional systems
Number of subjects: 51
Study 32318288 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate Variability (HRV) analysis
Number of subjects: 64
Study 32318288 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeostasis Evaluation Model (HOMA-IR)
Number of subjects: 64
Study 32318288 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity analysis
Number of subjects: 64
Study 32318288 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary time (ST) analysis
Number of subjects: 64
Study 32318288 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple linear regression for waist circumference (WC) and HOMA-IR
Number of subjects: 64
Study 32318288 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMA-IR and percentage of lipids ingested
Number of subjects: 64
Study 33825827 — intervention group
Group type: EXPERIMENTAL
Intervention: SlowMo plus usual care
Number of subjects: 361
Study 33825827 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 361
Study 32948442 — intervention group
Group type: EXPERIMENTAL
Intervention: Fellowship-trained chest radiologists
Number of subjects: 70
Study 32948442 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-chest fellowship-trained radiologists
Number of subjects: 70
Study 32948442 — intervention group
Group type: EXPERIMENTAL
Intervention: Fifth-year radiology residents
Number of subjects: 70
Study 32948442 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall agreement with PCR-confirmed COVID status
Number of subjects: 70
Study 36006657 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (Tisseel®)
Number of subjects: 90
Study 36006657 — intervention group
Group type: EXPERIMENTAL
Intervention: Omentopexy
Number of subjects: 90
Study 36006657 — intervention group
Group type: COMPARATOR
Intervention: No SLR (Control Group)
Number of subjects: 90
Study 33567041 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost
Number of subjects: 30
Study 33567041 — intervention group
Group type: COMPARATOR
Intervention: Selective laser trabeculoplasty
Number of subjects: 30
Study 32452356 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg once daily for 6 months
Number of subjects: 3127
Study 32452356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3127
Study 35954905 — intervention group
Group type: EXPERIMENTAL
Intervention: dCBT-i (sleep intervention group)
Number of subjects: 97
Study 35954905 — intervention group
Group type: COMPARATOR
Intervention: Conventional education (control group)
Number of subjects: 97
Study 35954905 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 97
Study 33607312 — intervention group
Group type: EXPERIMENTAL
Intervention: Rovalpituzumab tesirine (Rova-T) 0.3 mg/kg administered intravenously on day 1 of a 42-day cycle for two cycles.
Number of subjects: 444
Study 33607312 — intervention group
Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m2 administered intravenously on days 1 to 5 of a 21-day cycle.
Number of subjects: 444
Study 33607312 — intervention group
Group type: EXPERIMENTAL
Intervention: Rovalpituzumab tesirine (Rova-T)
Number of subjects: 444
Study 33930787 — intervention group
Group type: COMPARATOR
Intervention: RDA diet (0.8 g/kg body weight/d)
Number of subjects: 29
Study 33930787 — intervention group
Group type: EXPERIMENTAL
Intervention: 2RDA diet (2.0 g/kg body weight/d)
Number of subjects: 29
Study 32036958 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed restriction for 0, 4, 6, or 8 hours per day
Number of subjects: 2
Study 32036958 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed restriction for 4 to 8 hours
Number of subjects: 2
Study 32036958 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed restriction for 6 or more hours
Number of subjects: 2
Study 32036958 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed restriction (length not specified)
Number of subjects: 2
Study 35444030 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial HWLs on tobacco packages
Number of subjects: 276
Study 35444030 — intervention group
Group type: COMPARATOR
Intervention: Text only on tobacco package
Number of subjects: 276
Study 34769863 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral function training program
Number of subjects: 131
Study 34769863 — intervention group
Group type: COMPARATOR
Intervention: Physical function training
Number of subjects: 131
Study 32729919 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm for determining medication count
Number of subjects: 319
Study 32729919 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical IHC by the reference standard
Number of subjects: 319
Study 32729919 — intervention group
Group type: COMPARATOR
Intervention: Algorithm IHC false positives
Number of subjects: 319
Study 32729919 — intervention group
Group type: EXPERIMENTAL
Intervention: IHC with contributing conditions
Number of subjects: 319
Study 32729919 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined false-positive or IHC with contributing conditions
Number of subjects: 319
Study 32729919 — intervention group
Group type: EXPERIMENTAL
Intervention: Congestive heart failure as a contributing condition
Number of subjects: 319
Study 36235654 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intervention (Taste Education)
Number of subjects: 81
Study 36235654 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (Control)
Number of subjects: 81
Study 33529783 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) tranexamic acid (TXA) - two 1-g boluses, one prior to tourniquet inflation and one prior to wound closure
Number of subjects: 110
Study 33529783 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) tranexamic acid (TXA)
Number of subjects: 110
Study 34565369 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Conversations intervention (10 biweekly sessions led by trained peer facilitators)
Number of subjects: 60
Study 34565369 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (no intervention during the study period)
Number of subjects: 60
Study 35033043 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised Training Regimen (STR)
Number of subjects: 126
Study 35033043 — intervention group
Group type: COMPARATOR
Intervention: Home-Based Training Regimen (HTR)
Number of subjects: 126
Study 32142580 — intervention group
Group type: COMPARATOR
Intervention: Traditional maxillary and mandibular dentures (control)
Number of subjects: 18
Study 32142580 — intervention group
Group type: EXPERIMENTAL
Intervention: Stud overdentures
Number of subjects: 18
Study 32142580 — intervention group
Group type: EXPERIMENTAL
Intervention: Bar and telescopic overdentures
Number of subjects: 18
Study 32142580 — intervention group
Group type: EXPERIMENTAL
Intervention: Telescopic and stud overdentures
Number of subjects: 18
Study 32142580 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant overdentures
Number of subjects: 18
Study 34578863 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3-enriched Gouda-type cheese (5.7 μg of vitamin D3)
Number of subjects: 79
Study 33080406 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 39
Study 33080406 — intervention group
Group type: COMPARATOR
Intervention: Face bag-mask
Number of subjects: 39
Study 35921235 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL 200 mg plus MTX
Number of subjects: 56
Study 35921235 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL 100 mg plus MTX
Number of subjects: 56
Study 35921235 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL 200 mg
Number of subjects: 56
Study 35921235 — intervention group
Group type: COMPARATOR
Intervention: MTX
Number of subjects: 56
Study 33855215 — intervention group
Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (< 100 g carbohydrates/day)
Number of subjects: 10
Study 33855215 — intervention group
Group type: COMPARATOR
Intervention: High carbohydrate diet (> 250 g carbohydrates/day)
Number of subjects: 10
Study 32623701 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-IBS syrup (15 mL, thrice daily for 6 weeks)
Number of subjects: 70
Study 32623701 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup (similar preparation without plant extract)
Number of subjects: 70
Study 35723849 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone 30 mg by slow intravenous infusion for three days
Number of subjects: 38
Study 35723849 — intervention group
Group type: COMPARATOR
Intervention: Control group (national therapy only)
Number of subjects: 38
Study 32450057 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 0
Study 32450057 — intervention group
Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 0
Study 33073779 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP
Number of subjects: 132
Study 33073779 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HP
Number of subjects: 132
Study 33073779 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HP + CS
Number of subjects: 132
Study 33073779 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HP + TiO2
Number of subjects: 132
Study 33073779 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HP + TiO2 + CS
Number of subjects: 132
Study 33073779 — intervention group
Group type: COMPARATOR
Intervention: Control (no bleaching)
Number of subjects: 132
Study 36474005 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized digital coaching program (6 weeks)
Number of subjects: 109
Study 36474005 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 109
Study 35716695 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganaxolone
Number of subjects: 0
Study 35716695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34383325 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with a 980-nm diode laser set at 6.89 W/cm2 energy density, 0.5 W power, and a tip diameter of 10 mm for 15 seconds.
Number of subjects: 36
Study 34383325 — intervention group
Group type: COMPARATOR
Intervention: Sham group (laser handpiece placed but not activated).
Number of subjects: 36
Study 33073737 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo two-dose vaccination regimens
Number of subjects: 47
Study 33073737 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated implementation strategies
Number of subjects: 47
Study 33073737 — intervention group
Group type: COMPARATOR
Intervention: Standard implementation strategies
Number of subjects: 47
Study 36088369 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural safety training for medical students using participatory serious game design
Number of subjects: 27
Study 36088369 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural safety training
Number of subjects: 27
Study 33629227 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil 0.01%
Number of subjects: 215
Study 33629227 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02%
Number of subjects: 215
Study 33629227 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil 0.04%
Number of subjects: 215
Study 33629227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study 34578807 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein-based supplement
Number of subjects: 30
Study 34578807 — intervention group
Group type: COMPARATOR
Intervention: Regular endurance training without protein supplementation
Number of subjects: 30
Study 36114662 — intervention group
Group type: COMPARATOR
Intervention: Brachial artery responses during hypercapnia with arterial compression (compression arm)
Number of subjects: 14
Study 36114662 — intervention group
Group type: COMPARATOR
Intervention: Brachial artery responses during hypercapnia without α₁‐adrenergic receptor blockade (prazosin; 0.05 mg/kg)
Number of subjects: 14
Study 36114662 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery responses during hypercapnia with α₁‐adrenergic receptor blockade (prazosin; 0.05 mg/kg)
Number of subjects: 14
Study 33973307 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (nivolumab 1 mg/kg i.v. plus ipilimumab 3 mg/kg i.v. every 3 weeks for four cycles, followed by nivolumab 240 mg i.v. every 2 weeks)
Number of subjects: 0
Study 33973307 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab alone (not specified in the abstract but mentioned for comparison)
Number of subjects: 0
Study 33187563 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive Respiratory Muscle Training (RRMT)
Number of subjects: 24
Study 33187563 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Respiratory Muscle Training (ERMT)
Number of subjects: 24
Study 33187563 — intervention group
Group type: COMPARATOR
Intervention: Placebo Respiratory Muscle Training (PRMT)
Number of subjects: 24
Study 33187563 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 24
Study 34590926 — intervention group
Group type: EXPERIMENTAL
Intervention: Kyusho Jitsu intervention (twice a week for 6 months)
Number of subjects: 51
Study 34590926 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study 34590926 — intervention group
Group type: COMPARATOR
Intervention: Both groups (intervention and control)
Number of subjects: 51
Study 32811448 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional training intervention (INT)
Number of subjects: 40
Study 32811448 — intervention group
Group type: COMPARATOR
Intervention: Intradiaytic cycling control (CON)
Number of subjects: 40
Study 35509219 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ARD-101 (40, 100, and 240 mg)
Number of subjects: 43
Study 35509219 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ARD-101 (240 mg)
Number of subjects: 43
Study 35509219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 33259073 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypropylene (PP) transobturator slings
Number of subjects: 285
Study 33259073 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyvinylidene fluoride (PVDF) transobturator slings
Number of subjects: 285
Study 34851740 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a palliative care intervention (UC+PAL)
Number of subjects: 148
Study 34851740 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 148
Study 35322475 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% Fish Oil and 3% Rooibos
Number of subjects: 72
Study 35322475 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% Rooibos
Number of subjects: 72
Study 35322475 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish Oil and 3% Rooibos
Number of subjects: 72
Study 35322475 — intervention group
Group type: COMPARATOR
Intervention: 0% Fish Oil and Rooibos-free diets
Number of subjects: 72
Study 34505368 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 262
Study 34505368 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 262
Study 34378330 — intervention group
Group type: EXPERIMENTAL
Intervention: 34-session singing group programme (SGP)
Number of subjects: 149
Study 34378330 — intervention group
Group type: COMPARATOR
Intervention: Active waiting-list control
Number of subjects: 149
Study 32347887 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 27564
Study 32347887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27564
Study 35237340 — intervention group
Group type: EXPERIMENTAL
Intervention: Qinghe dispel paralysis soup
Number of subjects: 116
Study 35237340 — intervention group
Group type: COMPARATOR
Intervention: Loxoprofen sodium dispersible tablets
Number of subjects: 116
Study 33686482 — intervention group
Group type: EXPERIMENTAL
Intervention: Early sedation with dexmedetomidine (DEX)
Number of subjects: 3904
Study 33686482 — intervention group
Group type: COMPARATOR
Intervention: Usual care sedation
Number of subjects: 3904
Study 32183831 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen sponge insertion
Number of subjects: 31
Study 32183831 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 31
Study 33849908 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a cloth face mask during exercise
Number of subjects: 31
Study 33849908 — intervention group
Group type: COMPARATOR
Intervention: No cloth face mask during exercise
Number of subjects: 31
Study 33482328 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-synuclein (αS)
Number of subjects: 0
Study 32810203 — intervention group
Group type: EXPERIMENTAL
Intervention: 50W ablation group
Number of subjects: 150
Study 32810203 — intervention group
Group type: COMPARATOR
Intervention: 30W ablation group
Number of subjects: 150
Study 32810203 — intervention group
Group type: COMPARATOR
Intervention: 40W ablation group
Number of subjects: 150
Study 34191064 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant Stereotactic Radiosurgery (SRS) after surgery
Number of subjects: 0
Study 34191064 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant Stereotactic Radiosurgery (SRS) before resection
Number of subjects: 0
Study 34191064 — intervention group
Group type: COMPARATOR
Intervention: Postoperative observation after tumor removal
Number of subjects: 0
Study 32266730 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified education
Number of subjects: 271
Study 32266730 — intervention group
Group type: COMPARATOR
Intervention: Traditional ABCDEs education (Control)
Number of subjects: 271
Study 35532031 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser flush ablation (EVLAf) starting from the sapheno-femoral junction (SFJ)
Number of subjects: 146
Study 35532031 — intervention group
Group type: COMPARATOR
Intervention: Standard ablation (EVLAs) starting two cm below the SFJ
Number of subjects: 146
Study 35532031 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser flush ablation (EVLAf)
Number of subjects: 146
Study 35532031 — intervention group
Group type: COMPARATOR
Intervention: Standard ablation (EVLAs)
Number of subjects: 146
Study 33340729 — intervention group
Group type: EXPERIMENTAL
Intervention: Class II foot-sparing compression sleeves for the full leg
Number of subjects: 187
Study 33340729 — intervention group
Group type: COMPARATOR
Intervention: Class II stockings
Number of subjects: 187
Study 33734171 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow band CE-Chirp (NB CE-Chirp) at 500 Hz
Number of subjects: 21
Study 33734171 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow band CE-Chirp (NB CE-Chirp) at 1000 Hz
Number of subjects: 21
Study 32054300 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition program for adolescents with chronic conditions
Number of subjects: 0
Study 34129467 — intervention group
Group type: EXPERIMENTAL
Intervention: Propiverine hydrochloride
Number of subjects: 104
Study 35864493 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience educational intervention (8 training sessions using training clips, audio transmissions, and podcasts)
Number of subjects: 120
Study 35864493 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study 32935954 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor program activating therapy (MPAT), 1 hour, twice a week for two months.
Number of subjects: 38
Study 32935954 — intervention group
Group type: EXPERIMENTAL
Intervention: Vojta reflex locomotion (VRL), 1 hour, twice a week for two months.
Number of subjects: 38
Study 32935954 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls, underwent one fMRI examination.
Number of subjects: 38
Study 35081280 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (5 mg twice daily)
Number of subjects: 4352
Study 35081280 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (10 mg twice daily)
Number of subjects: 4352
Study 35081280 — intervention group
Group type: COMPARATOR
Intervention: TNF inhibitor
Number of subjects: 4352
Study 32790454 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconference-delivered single-session pain intervention
Number of subjects: 27
Study 32790454 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 27
Study 34370282 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 620
Study 34370282 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 620
Study 34370282 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics (SGA)
Number of subjects: 620
Study 34370282 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric comorbidity
Number of subjects: 620
Study 35012871 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming blankets
Number of subjects: 67
Study 35012871 — intervention group
Group type: COMPARATOR
Intervention: 100% cotton blankets
Number of subjects: 67
Study 33620516 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary diagnostic codes for RA
Number of subjects: 87